Over the past 12 months, 4 insiders at Nautilus Biotechnology, Inc. filed 7 open-market SEC Form 4 transactions on NAUT: 5 purchases worth $219K and 2 sales worth $11.8M. Insiders have been net buyers over this period. The most recent filing was on Jun 2, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 2, 26 | Ah Equity Partners Bio Ii, L.l.c. | SELL | 4.62M | $2.35 | $10.8M |
| Mar 4, 26 | Sujal M PatelCEO, President, and Secretary | BUY | 25.0K | $2.61 | $65K |
| Nov 6, 25 | Kentaro SuzukiChief Marketing Officer | BUY | 4.0K | $1.49 | $6K |
| Sep 8, 25 | Sujal M PatelCEO, President, and Secretary | BUY | 83.5K | $0.68 | $57K |
| Sep 5, 25 | Sujal M PatelCEO, President, and Secretary | BUY | 116.5K | $0.67 | $78K |
| Sep 4, 25 | Matthew B. MurphyGeneral Counsel | BUY | 20.0K | $0.64 | $13K |
| May 29, 25 | Anna MowryCFO and Treasurer | BUY | 15.0K | $0.77 | $12K |
| May 12, 25 | Parag MallickChief Scientist | BUY | 1.5K | $0.73 | $1K |
| May 8, 25 | Parag MallickChief Scientist | BUY | 12.0K | $0.73 | $9K |
| Mar 20, 25 | Sujal M PatelCEO, President, and Secretary | BUY | 23.9K | $1.00 | $24K |
| Mar 19, 25 | Sujal M PatelCEO, President, and Secretary | BUY | 53.3K | $0.99 | $53K |
| Sep 23, 24 | Mary E. GodwinSenior VP, Operations | SELL | 47.0K | $2.87 | $135K |
| Sep 17, 24 | Mary E. GodwinSenior VP, Operations | SELL | 35.0K | $2.85 | $100K |
| Mar 11, 24 | Sujal M PatelCEO, President, and Secretary | BUY | 12.0K | $2.84 | $34K |
| Mar 8, 24 | Sujal M PatelCEO, President, and Secretary | BUY | 2.4K | $2.99 | $7K |
| Mar 7, 24 | Sujal M PatelCEO, President, and Secretary | BUY | 18.9K | $2.89 | $54K |
| Mar 6, 24 | Sujal M PatelCEO, President, and Secretary | BUY | 9.3K | $2.70 | $25K |
| Mar 5, 24 | Sujal M PatelCEO, President, and Secretary | BUY | 7.4K | $2.65 | $20K |
| Sep 27, 22 | Subramanian SankarSenior VP, Product Development | BUY | 5.0K | $2.03 | $10K |
| Sep 26, 22 | Subramanian SankarSenior VP, Product Development | BUY | 10.0K | $2.03 | $20K |
| Sep 23, 22 | Gwen E WeldChief People Officer | BUY | 30.0K | $2.03 | $61K |
| Sep 16, 22 | Subramanian SankarSenior VP, Product Development | BUY | 35.0K | $2.16 | $76K |
| Sep 15, 22 | Subramanian SankarSenior VP, Product Development | BUY | 40.0K | $2.19 | $88K |
| Aug 19, 22 | Anna MowryCFO and Treasurer | BUY | 17.5K | $2.30 | $40K |
| Aug 15, 22 | Matthew B. MurphyGeneral Counsel | BUY | 7.5K | $2.84 | $21K |
| Aug 12, 22 | Matthew B. MurphyGeneral Counsel | BUY | 2.5K | $2.85 | $7K |
| Aug 8, 22 | Sujal M PatelCEO, President, and Secretary | BUY | 8.3K | $2.93 | $24K |
| Aug 5, 22 | Sujal M PatelCEO, President, and Secretary | BUY | 41.7K | $2.92 | $122K |
| Jun 27, 22 | Anna MowryCFO and Treasurer | BUY | 5.5K | $2.75 | $15K |
| May 9, 22 | Sujal M PatelCEO, President, and Secretary | BUY | 50.0K | $3.96 | $198K |
| Mar 3, 22 | Sujal M PatelCEO, President, and Secretary | BUY | 50.0K | $3.60 | $180K |
| Dec 8, 21 | Perceptive Life Sciences Master Fund LtdTenPercentOwner | BUY | 200.0K | $5.36 | $1.1M |
| Dec 1, 21 | Sujal M PatelCEO, President, and Secretary | BUY | 88.0K | $4.73 | $416K |
| Dec 1, 21 | Matthew L. PosardDirector | BUY | 10.0K | $4.50 | $45K |
| Nov 30, 21 | Sujal M PatelCEO, President, and Secretary | BUY | 162.0K | $4.72 | $765K |
| Nov 30, 21 | Matthew L. PosardDirector | BUY | 20.0K | $4.57 | $91K |
| Nov 24, 21 | Anna MowryCFO and Treasurer | BUY | 15.0K | $4.58 | $69K |
| Nov 15, 21 | Matthew S McIlwainDirector | BUY | 100.0K | $5.30 | $530K |
| Aug 26, 21 | Matthew S McIlwainDirector | BUY | 11.7K | $7.71 | $90K |
| Aug 25, 21 | Matthew S McIlwainDirector | BUY | 11.7K | $7.74 | $91K |
| Aug 24, 21 | Matthew S McIlwainDirector | BUY | 13.6K | $7.68 | $104K |
| Aug 13, 21 | Matthew B. MurphyGeneral Counsel | BUY | 5.0K | $7.56 | $38K |
| Aug 12, 21 | Anna MowryCFO and Treasurer | BUY | 17.5K | $7.71 | $135K |
Over the past 12 months, insiders at Nautilus Biotechnology, Inc. filed 5 open-market purchases worth $219K and 2 sales worth $11.8M on NAUT, which makes them net buyers over the period. The most recent Form 4 was filed on Jun 2, 26.
The largest recent open-market NAUT insider purchase in our data was $1.1M by Perceptive Life Sciences Master Fund Ltd, TenPercentOwner, filed on Dec 8, 21.
4 different insiders at Nautilus Biotechnology, Inc. filed open-market SEC Form 4 transactions on NAUT over the last 12 months.
InsiderTape plots every NAUT insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Nautilus Biotechnology, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →